Release Date: 18/10/21 16:13 Summary: Letter to Shareholders - Notice of AGM & Proxy Form Price Sensitive: No Download Document 308.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%